Lan Guo1, Wanggui Lu1, Xuan Zhang1, Dixian Luo1, Hongwen Zhang2. 1. Department of Gynaecology and Obstetrics, The First People's Hospital of Chenzhou City Chenzhou, HN 423000, China. 2. Department of Gynaecology and Obstetrics, The Second Xiangya Hospital Central South University Changsha, HN 410011, China.
Abstract
AIMS: To investigate metastasis associated in colon cancer 1 (MACC1) expression in cervical cancer. METHODS: One hundred and four paraffin-embedded cervical cancer specimens were immunohistochemically analyzed for MACC1 expression. The expression of MACC1 in 8 pairs of cervical cancer and adjacent normal cervical tissues were detected by Real-time PCR. RESULTS: MACC1 expression was upregulated in cervical cancer tissues compared with adjacent normal cervical tissues. Patients with higher MACC1 expression had shorter overall survival time, whereas those with lower ASAP1 expression survived longer (P = 0.029). Moreover, high expression of MACC1 was correlated with FIGO stage (P = 0.039) and lymph nodes metastasis (P = 0.003) of this disease. Multivariate analysis revealed that MACC1 was an independent prognostic factor (P = 0.043) for the overall survival of cervical cancer patients. CONCLUSION: Our study suggests that MACC1 may contribute to tumor development and progression in cervical cancer, and that MACC1 could be a useful marker for the prognosis of cervical cancer.
AIMS: To investigate metastasis associated in colon cancer 1 (MACC1) expression in cervical cancer. METHODS: One hundred and four paraffin-embedded cervical cancer specimens were immunohistochemically analyzed for MACC1 expression. The expression of MACC1 in 8 pairs of cervical cancer and adjacent normal cervical tissues were detected by Real-time PCR. RESULTS:MACC1 expression was upregulated in cervical cancer tissues compared with adjacent normal cervical tissues. Patients with higher MACC1 expression had shorter overall survival time, whereas those with lower ASAP1 expression survived longer (P = 0.029). Moreover, high expression of MACC1 was correlated with FIGO stage (P = 0.039) and lymph nodes metastasis (P = 0.003) of this disease. Multivariate analysis revealed that MACC1 was an independent prognostic factor (P = 0.043) for the overall survival of cervical cancerpatients. CONCLUSION: Our study suggests that MACC1 may contribute to tumor development and progression in cervical cancer, and that MACC1 could be a useful marker for the prognosis of cervical cancer.
Authors: Ulrich Nitsche; Robert Rosenberg; Alexander Balmert; Tibor Schuster; Julia Slotta-Huspenina; Pia Herrmann; Franz G Bader; Helmut Friess; Peter M Schlag; Ulrike Stein; Klaus-Peter Janssen Journal: Ann Surg Date: 2012-11 Impact factor: 12.969
Authors: Gaëlle A V Boulet; Caroline A J Horvath; Sarah Berghmans; Johannes Bogers Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-04 Impact factor: 4.254
Authors: Jack Cuzick; Christine Bergeron; Magnus von Knebel Doeberitz; Patti Gravitt; Jose Jeronimo; Attila T Lorincz; Chris J L M Meijer; Rengaswamy Sankaranarayanan; Peter J F Snijders; Anne Szarewski Journal: Vaccine Date: 2012-11-20 Impact factor: 3.641